| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -74,0 k € | +44.9% | -134,2 k € | -10.5% | -121,5 k € | +30.2% | -174,0 k € | +21.1% | -220,6 k € | -10.6% | -199,4 k € | +12.5% | -227,9 k € | -45.6% | -156,5 k € | -522.3% | -25,2 k € | -137.3% | -10,6 k € | |
| EBITDA | -74,4 k € | +49.1% | -146,0 k € | -19.6% | -122,0 k € | +30.1% | -174,5 k € | +21.1% | -221,1 k € | -10.6% | -199,9 k € | +12.5% | -228,3 k € | -45.5% | -157,0 k € | -513.1% | -25,6 k € | -124.4% | -11,4 k € | |
| Operating profit | -109,0 k € | +43.4% | -192,5 k € | -8.9% | -176,7 k € | +28.0% | -245,3 k € | +17.0% | -295,7 k € | -17.2% | -252,3 k € | +9.2% | -277,8 k € | -40.8% | -197,3 k € | -332.4% | -45,6 k € | -67.5% | -27,2 k € | |
| Profit/loss | -109,0 k € | +43.4% | -192,6 k € | -8.9% | -176,8 k € | +28.6% | -247,6 k € | +16.4% | -296,2 k € | -17.4% | -252,4 k € | +9.2% | -277,9 k € | -40.8% | -197,3 k € | -332.0% | -45,7 k € | -67.2% | -27,3 k € | |
| Equity | -177,3 k € | -159.8% | -68,2 k € | -185.5% | 79,8 k € | -34.4% | 121,6 k € | -67.1% | 369,2 k € | +536.7% | -84,5 k € | -198.5% | 85,8 k € | -76.4% | 363,7 k € | +84.6% | 197,0 k € | +38.1% | 142,7 k € | |
| Total assets | 50,7 k € | -33.4% | 76,2 k € | -30.1% | 108,9 k € | -27.0% | 149,3 k € | -62.3% | 395,6 k € | -7.8% | 428,9 k € | +77.1% | 242,2 k € | -38.5% | 393,8 k € | +98.2% | 198,7 k € | +34.5% | 147,7 k € | |
| Cash | 24,4 k € | +133.3% | 10,5 k € | +27.8% | 8,2 k € | +585.3% | 1,2 k € | -99.4% | 203,1 k € | -11.2% | 228,7 k € | +110.4% | 108,7 k € | -53.1% | 231,6 k € | +576.4% | 34,2 k € | -69.9% | 113,8 k € | |
| Debts | 228,0 k € | +57.9% | 144,4 k € | +395.6% | 29,1 k € | +5.3% | 27,7 k € | +5.1% | 26,3 k € | -94.9% | 513,5 k € | +228.4% | 156,4 k € | +420.4% | 30,0 k € | +1705.8% | 1,7 k € | -67.1% | 5,1 k € | |
Public limited company · Wevelgem · incorporated on 06/03/2015
Public limited company loss-making in the latest fiscal year. Cash position rising (+133.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
P & X Medical is a Public limited company incorporated in 2015. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Wevelgem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette